Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development.
Autoimmun Rev. 2021 Feb;20(2):102742. doi: 10.1016/j.autrev.2020.102742. Epub 2020 Dec 14.
Autoimmun Rev. 2021.
PMID: 33333235
Review.